A Covid-19 Strategy
SPECIAL FEATURE, 20 Jul 2020
17 Jul 2020 – To beat Covid-19, governments must drop ineffective strategies – including mass testing and tracing, mandatory face masks, lockdowns, or waiting for a hypothetical and experimental vaccine – and instead adopt an early treatment and prophylaxis strategy for people at high risk or high exposure.
This applies both to high-prevalence countries such as the US and to low-prevalence countries such as Germany. Lockdowns during an infection wave, in particular, are the worst possible approach as they isolate infected high-risk people until they develop serious respiratory problems.
Leading doctors from the US, Europe and Asia have reported striking success with early interventions based on zinc-chloroquine and zinc-quercetin combination protocols, including dramatic reductions in hospitalization and mortality rates and improvements in the condition of patients within hours.
The effectiveness of chloroquine against coronaviruses was discovered already back in 2005 in the wake of SARS-1. The fact that zinc blocks coronavirus RNA replication was discovered in 2010 by world-leading SARS virologist Ralph Baric. The fact that chloroquine and quercetin support cellular zinc uptake was discovered in 2014 in the context of cancer and virology research.
The alleged or actual negative results with chloroquine in some studies were based on delayed use (intensive care patients), excessive doses (up to 2400mg per day), manipulated data sets (the Surgisphere scandal), or ignored contraindications (e.g., favism or heart problems).
The lethality of Covid-19 is much lower than initially assumed – most people develop mild symptoms at most – but people at high risk or high exposure need early or prophylactic treatment.
In a recent two-part interview, US primary care physician Dr. Zev Zelenko, who has successfully treated more than 2000 Covid-19 patients, explained that further ignoring this simple and effective protocol, whether for political or for commercial reasons, would be a crime against humanity.
Note: Patients are asked to consult a doctor.
Swiss Policy Research, founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics that for personal and professional reasons prefer to protect their identities, and receives no external funding; there are no financial sponsors or backers. Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been translated into more than two dozen languages.
Tags: Airborne contagion, Brain, COVID-19, China, Community, Compassion, Coronavirus, Cuba, Economy, Empathy, Environment, Health, Lockdown, Pandemic, Public Health, Research, Science, Science and Medicine, Semen, Sharing, Sperm, Trade, United Nations, WHO, World
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Join the discussion!
We welcome debate and dissent, but personal — ad hominem — attacks (on authors, other users or any individual), abuse and defamatory language will not be tolerated. Nor will we tolerate attempts to deliberately disrupt discussions. We aim to maintain an inviting space to focus on intelligent interactions and debates.